Favorable Effects of Tacrolimus Monotherapy on Myasthenia Gravis Patients

Favorable Effects of Tacrolimus Monotherapy on Myasthenia Gravis Patients

Background and Purpose: Tacrolimus (TAC) has been proven to be a rapid-acting, steroid-sparing agent for myasthenia gravis (MG) therapy. However, evidence related to the effectiveness of TAC alone is rare. Therefore, this study was performed to investigate the effect of TAC monotherapy in MG patient...

Full description

Bibliographic Details
Main Authors: Zhirong Fan, Zunbo Li, Faxiu Shen, Xueping Zhang, Lin Lei, Shengyao Su, Yan Lu, Li Di, Min Wang, Min Xu, Yuwei Da
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Neurology
Subjects:
myasthenia gravis
tacrolimus
monotherapy
clinical effectiveness
adverse events
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2020.594152/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2020.594152/full

Similar Items